| | | 42237 | | 09.07.1980 | | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | | | | | | | | | | | | | | | 01.05.2004 | | | | |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Gaviscon | Liquidum | Suspension (oral) (Sodium Hydrogen Carbonate 170 mg, Calcium Carbonate 150 mg, Aluminii Oxidum Hydricum 200 mg, Sodium Alginate 500 mg) | A02AX | CI |
|
|
